-
University of Bristol, Imophoron to test Covid-19 vaccine candidates
pharmaceutical-technology
April 09, 2020
The University of Bristol and spin-out firm Imophoron are set to assess Covid-19 vaccine candidates in-vivo in a pre-clinical programme.
-
Oxford Biomedica joins consortium for promising COVID-19 vaccine
pharmatimes
April 08, 2020
As of this morning – Wednesday April 8 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 55,242 with 6,159 deaths
-
Johnson & Johnson announces a lead vaccine candidate for COVID-19
worldpharmanews
April 08, 2020
Johnson & Johnson announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020.
-
Inovio commences Phase I trial of DNA vaccine for Covid-19
pharmaceutical-technology
April 08, 2020
Inovio Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for the investigational new drug (IND) application of its DNA vaccine candidate INO-4800 against Covid-19.
-
GSK partners with Innovax Biotech on Covid-19 vaccine
pharmaceutical-technology
April 07, 2020
GlaxoSmithKline (GSK) has partnered with Xiamen Innovax Biotech to support the development of a recombinant protein-based vaccine candidate against Covid-19.
-
Covid-19 vaccine candidate yields promising data in mice
pharmaceutical-technology
April 06, 2020
Researchers at the University of Pittsburgh School of Medicine in the US have reported encouraging results from initial tests of a Covid-19 vaccine candidate, PittCoVacc, delivered using a fingertip-sized patch in mice.
-
FluGen, Bharat Biotech and UW–Madison partner on Covid-19 vaccine
pharmaceutical-technology
April 06, 2020
Vaccine development companies FluGen and Bharat Biotech have partnered with the University of Wisconsin–Madison (UWMadison) to develop and evaluate a Covid-19 vaccine candidate, CoroFlu.
-
Thermo Fisher Scientific to enhance capacity for COVID-19 testing in India
expresspharma
April 06, 2020
Thermo Fisher Scientific announced that it is accelerating its efforts with diagnostic testing and vaccine development technologies to effectively manage COVID-19 outbreak in the country.
-
Johnson & Johnson Announces Lead Vaccine Candidate for COVID-19, Partners with HHS
americanpharmaceuticalreview
April 03, 2020
Johnson & Johnson announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020.
-
Israeli scientists begin animal testing of Covid-19 vaccine prototype
pharmaceutical-technology
April 03, 2020
The Israel Institute for Biological Research (IIBR) has made ‘significant’ progress in creating a Covid-19 vaccine prototype and preparations are underway for animal testing, said Prime Minister Benjamin Netanyahu.